25 May 2013
Keywords: zeneca, praises, 1st, half, underlying, growth, demerger
Article | 08 August 1994
A year since the demerger of the biosciences business from ICI, Zeneca has experienced a period of many changes, not ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.